The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol

NCT00283335 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2531

Enrollment

FED

Sponsor class

Conditions

Coronary Heart Disease

Interventions

DRUG: gemfibrozil
OTHER: Placebo

Sponsor

VA Office of Research and Development

Collaborators

[object Object]
[object Object]